What does CUSIP 04351P101 represent in this 13F holders report?

CUSIP 04351P101 is the security identifier for ASND - Ascendis Pharma A/S - Common Stock used to aggregate holder disclosures.

How many institutions held ASND - Ascendis Pharma A/S - Common Stock in Q1 2021?

172 institutional investors reported ASND - Ascendis Pharma A/S - Common Stock for Q1 2021. Use the holders table for investor-level position and value details.

Ascendis Pharma A/S - Common Stock (ASND)

CUSIP: 04351P101

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock
Shares outstanding: 61,152,075
Total 13F shares: 52,687,197
Share change: -1,447,796
Total reported value: $6,790,538,552
Put/Call ratio: 104%
Price per share: $128.88
Number of holders: 172
Value change: -$259,999,867
Number of buys: 102
Number of sells: 75

Quarterly Holders Quick Answers

What is CUSIP 04351P101?
CUSIP 04351P101 identifies ASND - Ascendis Pharma A/S - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 04351P101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ASND - Ascendis Pharma A/S - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	11%	6,619,042	$1,103,924,000	—	31 Dec 2020	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	9.6%	5,865,338	$978,221,000	—	31 Dec 2020	13F
Artisan Partners Limited Partnership	13F	Company	9.4%	5,767,527	$961,908,000	—	31 Dec 2020	13F
FMR LLC	13F	Company	8.7%	5,341,609	$890,874,000	—	31 Dec 2020	13F
BAKER BROS. ADVISORS LP	13F	Company	5.8%	3,540,270	$590,446,000	—	31 Dec 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	5.6%	3,401,558	$567,313,000	—	31 Dec 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	4.9%	3,008,829	$501,805,000	—	31 Dec 2020	13F
Avoro Capital Advisors LLC	13F	Company	2.9%	1,800,000	$300,204,000	—	31 Dec 2020	13F
Vivo Capital, LLC	13F	Company	2.9%	1,797,745	$299,828,000	—	31 Dec 2020	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	2.8%	1,729,881	$288,510,000	—	31 Dec 2020	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	2.8%	1,704,148	$284,218,000	—	31 Dec 2020	13F
Sofinnova Investments, Inc.	13F	Company	1.8%	1,109,874	$185,105,000	—	31 Dec 2020	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	1.6%	1,000,000	$166,780,000	—	31 Dec 2020	13F
LONE PINE CAPITAL LLC	13F	Company	1.5%	894,533	$149,190,000	—	31 Dec 2020	13F
Invesco Ltd.	13F	Company	1.3%	766,704	$127,871,000	—	31 Dec 2020	13F
FRANKLIN RESOURCES INC	13F	Company	1.2%	732,063	$122,094,000	—	31 Dec 2020	13F
Spyglass Capital Management LLC	13F	Company	1.1%	701,594	$117,012,000	—	31 Dec 2020	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	1.1%	698,941	$116,569,000	—	31 Dec 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.83%	507,758	$84,684,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	0.76%	462,663	$77,163,000	—	31 Dec 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.76%	462,533	$77,141,000	—	31 Dec 2020	13F
TimesSquare Capital Management, LLC	13F	Company	0.71%	433,200	$72,249,000	—	31 Dec 2020	13F
ORBIMED ADVISORS LLC	13F	Company	0.55%	336,500	$56,121,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.52%	320,014	$53,372,000	—	31 Dec 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.44%	270,842	$45,171,000	—	31 Dec 2020	13F
Marshall Wace North America L.P.	13F	Company	0.44%	268,098	$44,713,000	—	31 Dec 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.43%	261,578	$43,627,000	—	31 Dec 2020	13F
SEI INVESTMENTS CO	13F	Company	0.4%	243,102	$40,551,000	—	31 Dec 2020	13F
S.c.a. Candriam	13F	Individual	0.39%	240,671	$40,141,000	—	31 Dec 2020	13F
Rock Springs Capital Management LP	13F	Company	0.38%	233,500	$38,943,000	—	31 Dec 2020	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.34%	210,679	$35,137,000	—	31 Dec 2020	13F
Eversept Partners, LP	13F	Company	0.31%	187,043	$31,195,032	—	31 Dec 2020	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.3%	184,320	$30,741,000	—	31 Dec 2020	13F
FIL Ltd	13F	Company	0.27%	163,524	$27,273,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.26%	162,024	$27,023,000	—	31 Dec 2020	13F
LOOMIS SAYLES & CO L P	13F	Company	0.26%	157,636	$26,291,000	—	31 Dec 2020	13F
Neuberger Berman Group LLC	13F	Company	0.21%	130,500	$21,765,000	—	31 Dec 2020	13F
TD ASSET MANAGEMENT INC	13F	Company	0.21%	126,781	$21,145,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.19%	118,121	$19,700,000	—	31 Dec 2020	13F
Ghost Tree Capital, LLC	13F	Company	0.17%	105,000	$17,512,000	—	31 Dec 2020	13F
Cormorant Asset Management, LP	13F	Company	0.16%	100,000	$16,678,000	—	31 Dec 2020	13F
Tekla Capital Management LLC	13F	Company	0.16%	96,246	$16,052,000	—	31 Dec 2020	13F
LAKEWOOD CAPITAL MANAGEMENT, LP	13F	Company	0.16%	95,450	$15,919,000	—	31 Dec 2020	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0.15%	93,600	$15,610,000	—	31 Dec 2020	13F
Ikarian Capital, LLC	13F	Company	0.14%	87,090	$14,526,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.14%	85,991	$14,342,000	—	31 Dec 2020	13F
J.P. Morgan Private Wealth Advisors LLC	13F	Company	0.13%	77,788	$12,973,000	—	31 Dec 2020	13F
WESTPAC BANKING CORP	13F	Company	0.13%	77,527	$12,929,952	—	31 Dec 2020	13F
BERYLSON CAPITAL PARTNERS, LLC	13F	Company	0.12%	72,700	$12,125,000	—	31 Dec 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.11%	70,156	$11,700,000	—	31 Dec 2020	13F

Institutional Holders of Ascendis Pharma A/S - Common Stock (ASND) as of Q1 2021

As of 31 Mar 2021, Ascendis Pharma A/S - Common Stock (ASND) was held by 172 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 52,687,197 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Artisan Partners Limited Partnership, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, JANUS HENDERSON GROUP PLC, WESTFIELD CAPITAL MANAGEMENT CO LP, EVENTIDE ASSET MANAGEMENT, LLC, and Vivo Capital, LLC. This page lists 173 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

173

Q1 2021 holders

172

Holder diff

-1

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.